Abstract
Flow cytometry is a powerful technique for the detection and quantification of cell surface and intracellular proteins. It enables the ability to measure the expression levels of specific proteins in a cell population of interest without the need to physically separate out the cells from within a heterogeneous population by using the appropriate cell-specific markers. It also requires fewer cells than other traditional techniques such as Western blotting. Here we describe a robust and reproducible method to measure the expression levels of the BCL-2 family members, BCL-2, BCL-XL, and MCL-1 by quantitative flow cytometry (QFCM) using validated antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Meehan RT, Neale LS, Kraus ET, Stuart CA, Smith ML, Cintron NM (1992) Alterations in human mononuclear leucocyte following space flight. Immunology 76:491–497
Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A (2017) Flow cytometry: basic principles and applications. Crit Rev Biotechnol 37:163–176
Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, et al (2008) ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68:3421–3428
Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J et al (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202–208
Smith ML, Chyla B, McKeegan E, Tahir SK (2017) Development of a flow cytometric method for quantification of BCL-2 family members in chronic lymphocytic leukemia and correlation with sensitivity to BCL-2 family inhibitors. Cytometry B Clin Cytom 92:331–339
Konopleva M, Pollyea DA, Potluri J, Chyla B, Hogdal L, Busman T et al (2016) Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov 6:1106–1117
Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49–63
Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ (2017) From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 16:273–284
Wong M, Tan N, Zha J, Peale FV, Yue P, Fairbrother WJ et al (2012) Navitoclax (ABT-263) reduces Bcl-xL-mediated chemo-resistance in ovarian cancer models. Mol Cancer Ther 11:1026–1035
van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GMJM, Westra AH et al (2003) A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. Leukemia 17:780–786
Varela M, Ranuncolo SM, Morand A, Lastiri J, De Kier Joffé EB, Puricelli LI et al (2004) EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol 4:34–40
Marcucci G, Stock W, Dai G, Klisovic RB, Liu S, Klisovic MI et al (2005) Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. J Clin Oncol 23:3404–3411
Ding M, Kaspersson K, Murray D, Bardelle C (2017) High-throughput flow cytometry for drug discovery: principles, applications, and case studies. Drug Discov Today 22:1844–1850
Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J et al (2010) Antibody validation. BioTechniques 48:197–209
O'Hara DM, Xu Y, Liang Z, Reddy MP, Wu DY, Litwin V (2011) Recommendations for the validation of flow cytometric testing during drug development: II assays. J Immunol Methods 363:120–134
Craig FE, Foon KA (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111:3941–3967
Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R (2003) Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Med Sci Monit 9:359–362
Stewart CC, Stewart SJ (2001) Cell preparation for the identification of leukocytes. Methods Cell Biol 63:217–251
Phillips DC, Garrison SP, Jeffers JR, Zambetti GP (2009) Assays to measure p53-dependent and independent apoptosis. Methods Mol Biol 559:143–159
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Smith, M.L., Tahir, S.K. (2019). Quantification of BCL-2 Family Members by Flow Cytometry. In: Gavathiotis, E. (eds) BCL-2 Family Proteins. Methods in Molecular Biology, vol 1877. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8861-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8861-7_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8860-0
Online ISBN: 978-1-4939-8861-7
eBook Packages: Springer Protocols